[Variability in coronary risk assessment in HIV-infected patients]

Milagros García-Lázaro1, Antonio Rivero Román, Angela Camacho Espejo

  • 1Sección de Enfermedades Infecciosas, Hospital Universitario Reina Sofía, Córdoba, España. milagrosglazaro@telefonica.net

Medicina Clinica
|November 7, 2007
PubMed

Insights

Assessing coronary risk (CR) in HIV patients is crucial. The Framingham tables may overestimate CR compared to REGICOR, highlighting the need for accurate risk assessment tools in this population.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Antiretroviral treatment in HIV-infected patients may increase coronary risk (CR).
  • Accurate CR assessment is vital for managing HIV patients.
  • Cardiovascular disease is a growing concern in the aging HIV population.

Purpose of the Study:

  • To compare the 10-year CR assessment between Framingham and REGICOR tables in HIV-infected patients.
  • To evaluate the prevalence of cardiovascular risk factors in this cohort.

Main Methods:

  • Prospective cohort study of 205 HIV-infected patients.
  • Calculation of 10-year CR using Framingham and REGICOR adapted tables.
  • Assessment of cardiovascular risk factors including smoking, dyslipidemia, hypertension, diabetes, lipodystrophy, obesity, and lifestyle.

Main Results:

  • Mean age was 41.4 years; most patients were on antiretrovirals with good immunological status.
  • High prevalence of current smoking (77.1%), dyslipidemia (29.3%), and sedentary lifestyle (50.7%).
  • Framingham tables indicated 12.9% of patients had >10% 10-year CR, versus 2.0% with REGICOR tables (p < 0.001).

Conclusions:

  • Framingham tables may overestimate coronary risk in HIV-infected patients.
  • Further research is needed to determine the most appropriate CR assessment method for HIV patients.
  • Caution is advised when estimating CR in HIV-infected individuals until validated methods are established.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...